|
시장보고서
상품코드
2050604
감염증 진단 시장 : 기술별, 질환별(설사성 질환, 호흡기 감염증, 혈액 감염증, 성감염증), 최종사용자별, 지역별Infectious Disease Diagnostics Market, By Technology, By Disease Indication, Diarrheal Disease,Respiratory Infections,Blood Infections,STDs, By End User, By Geography |
||||||
감염증 진단 시장은 2026년에 19억 2,610만 달러로 추계되고 있으며, 2033년까지 37억 5,570만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 10.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 19억 2,610만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 10.00% | 2033년 시장 규모 예측 : | 37억 5,570만 달러 |
감염은 박테리아, 바이러스, 곰팡이, 기생충 등 미생물에 의해 발생하며, 한 종에서 다른 종으로 전파될 수 있습니다. 감염병은 직접적인 접촉이나 곤충의 물림, 음식, 토양, 물, 공기 등의 매개체를 통해 간접적으로 사람에서 사람으로 전파됩니다. 이러한 질환의 진단에는 병원체와 그 유형를 확인하고 감염이 어디까지 퍼졌는지 진단하는 것이 포함됩니다. 진단은 질병을 발견하는 첫 번째 단계이며, 그 치료는 감염을 근절하는 데 도움이 됩니다. 감염성 질환은 이환율과 사망률의 주요 원인 중 하나입니다. 진단은 모든 임상 치료의 진행 방식을 결정하는 데 중요한 역할을 합니다. 감염병 진단은 병원체에 의한 질병 진단에 도움이 되는데, HIV, 결핵, 말라리아, 독감 등의 감염병은 유병률이 높아 각 질환에 맞는 진단 검사를 활용하면 효율적으로 진단할 수 있습니다. 기존의 감염성 질환 진단은 시간이 오래 걸렸습니다. 이러한 요인으로 인해 감염성 질환 진단 시장에서는 신속하고 정확하며 휴대가 가능한 현장 검사 제품이 등장하고 있습니다. Point-of-Care 검사는 환자 가까이에서 감염병을 신속하게 진단할 수 있으며, 즉각적인 결과를 제공합니다. 현재 많은 연구자들이 다중 POC(Point-Of-Care) 진단 기술을 개발하기 위해 노력하고 있습니다. 이러한 진단 검사에 활용되는 기술은 생화학적 기법, 분자생물학적 기법, 면역진단법, 전통적 배양법, 염색법 등으로 분류됩니다. 생화학적 방법으로는 효소면역측정법(ELISA), 응집반응 등이 있으며, 분자생물학적 방법으로는 중합효소연쇄반응(PCR), 차세대 염기서열분석 기술 등이 있습니다. 이러한 검사는 높은 처리 능력을 갖추고 있으며, 감염성 질환을 정확하게 진단할 수 있습니다.
시장 역학
조기 진단에 대한 인식이 높아짐에 따라 감염성 질환 진단 시장의 보급 확대는 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 1995년 미국 질병예방통제센터(CDC)의 보고에 따르면 미국 병원의 병원내 감염(HAI)은 연간 170만 건의 감염과 9만 9,000명의 사망을 유발하는 것으로 나타났습니다. 이 중 요로감염은 전체 의료관련 감염의 최대 32%를 차지하며, 수술부위 감염[22%], 폐렴[15%], 혈류감염[14%]이 그 뒤를 잇고 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 매출 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서에서는 세계 감염병 진단 시장의 주요 기업 개요을 회사 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 개발, 전략 및 향후 계획 등의 정보를 정리하여 전해드립니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계의 감염병 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 감염증 진단 시장 : 기술별, 2021-2033년
제5장 세계의 감염증 진단 시장 : 질환 적응증별, 2021-2033년
제6장 세계의 감염증 진단 시장 : 최종사용자별, 2021-2033년
제7장 세계의 감염증 진단 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.06.10Infectious Disease Diagnostics Market is estimated to be valued at USD 1,926.1 Mn in 2026 and is expected to reach USD 3,755.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,926.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.00% | 2033 Value Projection: | USD 3,755.7 Mn |
Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.
Market Dynamics
Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
- Technology Insights (Revenue, USD Mn & KT, 2026 - 2033)
- ELISA
- Polymerase Chain Reaction
- Immunoassays
- Cell Cultures
- Others
- Disease Indication Insights (Revenue, USD Mn & KT, 2026 - 2033)
- Central nervous system (CNS) Infection
- Meningitis
- Brain Abscess
- Diarrheal Disease
- Shigellosis
- Cholera
- Enteric/Typhoid Fever
- Respiratory Infections
- Tuberculosis
- Influenza
- Bronchitis
- Blood Infections
- Malaria
- Dengue
- Infectious Mononucleosis
- Others
- STDs
- Chlamydia
- AIDS
- Syphilis
- Others
- End User Insights (Revenue, USD Mn & KT, 2026 - 2033)
- Hospitals
- Diagnostics centers
- Dermatology Clinics
- Others (Research Institutes, Specialty Centres, etc.)
- Regional Insights (Revenue, USD Mn & KT, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players Insights
- Becton Dickinson & Company
- Cepheid, Inc
- Abbott Laboratories
- BioMerieux SA
- Hologic, Inc
- Danaher Corporation
- Thermo Fisher Scientific, Inc
- Roche Diagnostics
- DiaSorin S.p.A
- Quidel Corporation
- Bio-Rad Laboratories
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Disease Indication
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
4. Global Infectious Disease Diagnostics Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
- Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
- Cell Cultures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
5. Global Infectious Disease Diagnostics Market , By Disease Indication 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Central Nervous System Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Meningitis
- Brain Abscess
- Diarrheal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Shigellosis
- Cholera
- Enteric/Typhoid Fever
- Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Tuberculosis
- Influenza
- Bronchitis
- Blood Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Malaria
- Dengue
- Infectious Mononucleosis
- Others
- Sexually transmitted diseases (STDs),
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Chlamydia
- AIDS
- Syphilis
- Others
6. Global Infectious Disease Diagnostics Market , By End Users 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others (Research Institutes, Specialty Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Infectious Disease Diagnostics Market , By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Becton Dickinson & Company
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Cepheid, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Abbott Laboratries
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- BioMerieux
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Danaher Corportion
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Quidel Corporation
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
9. Section
- Research Methodology
- About Us
